Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)

NCT01425190 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class

Stopped The US FDA and the EU CHMP provided guidance indicating preference for intereferon-free regimens in pediatric studies of HCV infection.

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC